Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about NADH: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
NADH is a concept in neurodegeneration research. Key relationships include: regulates, activates, implicated in. Associated with AD, ADH, ALI. Connected to 218 entities in the SciDEX knowledge graph.
No AI portrait yet
| Name | NADH |
| Key Genes/Proteins | ACETYL-COA, ACTB, Actin, AGING, AIF, AKT |
| Related Diseases | AD, ADH, Aging, ALI, Als |
Knowledge base pages for this entity
graph TD
NADH["NADH"]
NADH -->|"regulates"| Ischemia["Ischemia"]
NADH -->|"activates"| Metabolic_Syndrome["Metabolic Syndrome"]
NADH -->|"regulates"| Tumor["Tumor"]
NADH -->|"regulates"| Neurodegeneration["Neurodegeneration"]
NADH -->|"regulates"| Cancer["Cancer"]
NADH -->|"activates"| Aging["Aging"]
NADH -.protects against.-> Neuroinflammation["Neuroinflammation"]
NADH -.protects against.-> Traumatic_Brain_Injury["Traumatic Brain Injury"]
NADH -.protects against.-> Inflammation["Inflammation"]
NADH -.protects against.-> Alzheimer["Alzheimer"]
EEF2["EEF2"] -->|"binds"| NADH
METHYLENE_BLUE["METHYLENE_BLUE"] -->|"interacts"| NADH
MTOR["MTOR"] -->|"regulates"| NADH
MYC["MYC"] -->|"regulates"| NADH
EGFR["EGFR"] -->|"regulates"| NADH
MTORC1["MTORC1"] -->|"regulates"| NADH
RPS6["RPS6"] -->|"regulates"| NADH
CTSD["CTSD"] -->|"regulates"| NADH
ATG["ATG"] -->|"regulates"| NADH
NAD["NAD"] -->|"regulates"| NADH| Target | Relation | Type | Str |
|---|---|---|---|
| Als | activates | disease | 0.85 |
| NAD+ metabolism | participates_in | pathway | 0.85 |
| SIRT1 | activates | gene | 0.75 |
| Cancer | associated_with | disease | 0.75 |
| Oxidative Stress | activates | pathway | 0.70 |
| MITOCHONDRIA | activates | gene | 0.70 |
| oxidative stress response | participates_in | pathway | 0.70 |
| Mitochondrial Function | activates | pathway | 0.70 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Parkinson | therapeutic_target | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Stroke | therapeutic_target | disease | 0.65 |
| Neurodegeneration | therapeutic_target | disease | 0.65 |
| Neuroinflammation | therapeutic_target | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | associated_with | disease | 0.65 |
| Als | protects_against | disease | 0.65 |
| Huntington | associated_with | disease | 0.65 |
| Sepsis | activates | disease | 0.65 |
| Senescence | associated_with | disease | 0.65 |
| Cancer | regulates | disease | 0.65 |
| Infection | activates | disease | 0.65 |
| Neurodegeneration | regulates | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Tumor | regulates | disease | 0.65 |
| Ischemia | therapeutic_target | disease | 0.65 |
| Anxiety | inhibits | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| ALS | associated_with | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Diabetes | activates | disease | 0.65 |
| Traumatic Brain Injury | implicated_in | disease | 0.65 |
| Neuroinflammation | implicated_in | disease | 0.65 |
| Stroke | implicated_in | disease | 0.65 |
| Inflammation | implicated_in | disease | 0.65 |
| Aging | expressed_in | disease | 0.65 |
| Fatty Liver | activates | disease | 0.65 |
| Dementia | expressed_in | disease | 0.65 |
| Alzheimer | expressed_in | disease | 0.65 |
| neurons | expressed_in | cell_type | 0.65 |
| Obesity | activates | disease | 0.65 |
| ALS | expressed_in | disease | 0.65 |
| Traumatic Brain Injury | protects_against | disease | 0.65 |
| Ischemia | regulates | disease | 0.65 |
| Lung Cancer | associated_with | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Ischemia | protects_against | disease | 0.65 |
| Stroke | activates | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Alzheimer | protects_against | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Methylene Blue | interacts_with | drug | 0.90 |
| IDH2 | associated_with | entity | 0.90 |
| IDH1 | associated_with | entity | 0.90 |
| EEF2 | binds | gene | 0.80 |
| NAD | inhibits | gene | 0.70 |
| OXIDATIVE STRESS | activates | gene | 0.70 |
| CANCER | associated_with | gene | 0.70 |
| NAD | causes | gene | 0.65 |
| ISCHEMIA | regulates | disease | 0.65 |
| ATP | regulates | gene | 0.65 |
| NAD | biomarker_for | gene | 0.65 |
| METHYLENE_BLUE | interacts_with | drug | 0.64 |
| ATG | activates | gene | 0.60 |
| ATP | activates | gene | 0.60 |
| CAT | activates | gene | 0.60 |
| CPT1A | activates | gene | 0.60 |
| MTOR | activates | gene | 0.60 |
| rapamycin | targets | drug | 0.60 |
| GENES | activates | gene | 0.60 |
| PPAR | activates | gene | 0.60 |
| SIRT1 | activates | gene | 0.60 |
| SREBF1 | regulates | gene | 0.60 |
| ALS | interacts_with | gene | 0.60 |
| NAD | activates | gene | 0.60 |
| HIF | activates | gene | 0.60 |
| LC3B | associated_with | gene | 0.60 |
| AND | regulates | gene | 0.60 |
| HUNTINGTON'S DISEASE | associated_with | gene | 0.60 |
| ALS | associated_with | gene | 0.60 |
| APOPTOSIS | associated_with | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| LAMP1 | regulates | gene | 0.60 |
| PPARA | regulates | gene | 0.60 |
| MAP1LC3C | associated_with | gene | 0.60 |
| CPT1A | regulates | gene | 0.60 |
| PPARGC1A | regulates | gene | 0.60 |
| EIF4EBP1 | regulates | gene | 0.60 |
| ROS | associated_with | gene | 0.60 |
| ATG14 | associated_with | gene | 0.60 |
| NDUFV2 | associated_with | gene | 0.60 |
| CD38 | associated_with | gene | 0.60 |
| DNA | associated_with | gene | 0.60 |
| NAD | phosphorylates | gene | 0.60 |
| MITOCHONDRIAL DYSFUNCTION | associated_with | gene | 0.60 |
| MTDNA | activates | gene | 0.60 |
| AMPK | associated_with | gene | 0.60 |
| AGING | associated_with | gene | 0.60 |
| AND | phosphorylates | gene | 0.60 |
| NAMPT | associated_with | gene | 0.60 |
| NEUROINFLAMMATION | protects_against | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-04 | 0 hypotheses
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning NADH in their description or question text
No additional research found